Sana Biotechnology Inc SANA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/10/24 EDT
7.56UNCH (UNCH)
Volume
4,613
Close
7.56quote price arrow up+0.06 (+0.80%)
Volume
3,831,501
52 week range
2.74 - 12.00
Loading...
  • Open7.52
  • Day High7.97
  • Day Low7.40
  • Prev Close7.50
  • 52 Week High12.00
  • 52 Week High Date03/01/24
  • 52 Week Low2.74
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.673B
  • Shares Out221.32M
  • 10 Day Average Volume2.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change85.29

KEY STATS

  • Open7.52
  • Day High7.97
  • Day Low7.40
  • Prev Close7.50
  • 52 Week High12.00
  • 52 Week High Date03/01/24
  • 52 Week Low2.74
  • 52 Week Low Date10/27/23
  • Market Cap1.673B
  • Shares Out221.32M
  • 10 Day Average Volume2.16M
  • Dividend-
  • Dividend Yield-
  • Beta1.82
  • YTD % Change85.29

RATIOS/PROFITABILITY

  • EPS (TTM)-1.53
  • P/E (TTM)-4.95
  • Fwd P/E (NTM)-6.70
  • EBITDA (TTM)-295.767M
  • ROE (TTM)-76.82%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/01/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sana Biotechnology Inc

 

Profile

MORE
Sana Biotechnology, Inc. is a biotechnology company focusing on utilizing engineered cells as medicines. It is engaged in developing cell engineering programs to revolutionize treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune and central nervous system disorders. It develops a pipeline of clinical product candidates focused on creating transformative ex vivo therapies across a range of...
Richard Mulligan Ph.D.
Vice Chairman of the Board and Head of SanaX
Hans Bishop
Independent Chairman of the Board
Steven Harr M.D.
President, Chief Executive Officer, Director
Nathan Hardy
Chief Financial Officer, Executive Vice President
Bernard Cassidy
Executive Vice President, General Counsel, Company Secretary
Address
188 East Blaine Street, Suite 400
Seattle, WA
98102
United States

Top Peers

SYMBOLLASTCHG%CHG
GERN
Geron Corp
3.80-0.08-2.06%
DYN
Dyne Therapeutics Inc
26.00+0.05+0.19%
KROS
Keros Therapeutics Inc
54.27-3.33-5.78%
RCKT
Rocket Pharmaceuticals Inc
22.72-0.61-2.61%
RNA
Avidity Biosciences Inc
25.96-1.14-4.21%